We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M Turnover 16.91%
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$9.62M
Cap. Flow
+$2.42M
Cap. Flow %
1.74%
Top 10 Hldgs %
27.84%
Holding
157
New
14
Increased
39
Reduced
52
Closed
19
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.67%
2 Energy 14.21%
3 Technology 10.78%
4 Healthcare 9.81%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WEN icon
26
Wendy's
WEN
$1.28B
$1.57M 1.12%
184,650
-40,100
-18% -$301K
2013 Q2
1 quarter
CHL
27
DELISTED
China Mobile Limited
CHL
$1.55M 1.11%
27,500
+11,150
+68% +$603K
2013 Q2
1 quarter
CHSCP icon
28
CHS Inc 8% Preferred Stock
CHSCP
$318M
$1.53M 1.1%
51,324
– –
2013 Q2
1 quarter
ABR icon
29
Arbor Realty Trust
ABR
$522M
$1.51M 1.08%
222,110
+13,700
+7% +$96.9K
2013 Q2
1 quarter
CNOB icon
30
Center Bancorp
CNOB
$1.53B
$1.46M 1.05%
102,554
– –
2013 Q2
1 quarter
META icon
31
Meta Platforms (Facebook)
META
$1.88T
$1.45M 1.04%
+28,845
New +$1.07M
2013 Q3
0 quarters
WPRT icon
32
Westport Fuel Systems
WPRT
$34.6M
$1.45M 1.04%
5,990
+400
+7% +$117K
2013 Q2
1 quarter
MILL
33
DELISTED
MILLER ENERGY RESOURCES, INC COM STK
MILL
$1.37M 0.98%
+188,200
New +$1.05M
2013 Q3
0 quarters
MFA icon
34
MFA Financial
MFA
$677M
$1.28M 0.92%
43,125
+3,975
+10% +$122K
2013 Q2
1 quarter
TRIB
35
Trinity Biotech
TRIB
$6.45M
$1.24M 0.89%
380
+36
+10% +$105K
2013 Q2
1 quarter
SSW.PRC
36
DELISTED
SEASPAN CORP 9.50% SER C RED PERP PFD SHS (MHL)
SSW.PRC
$1.16M 0.83%
42,618
+1,461
+4% +$39.3K
2013 Q2
1 quarter
WU icon
37
Western Union
WU
$1.94B
$1.14M 0.82%
61,300
+8,200
+15% +$147K
2013 Q2
1 quarter
PHYS icon
38
Sprott Physical Gold
PHYS
$14.9B
$1.11M 0.8%
100,600
-200
-0.2% -$2.22K
2013 Q2
1 quarter
ETN icon
39
Eaton
ETN
$156B
$1.11M 0.8%
16,100
+4,500
+39% +$302K
2013 Q2
1 quarter
GS.PRA icon
40
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$580M
$1.11M 0.8%
55,452
– –
2013 Q2
1 quarter
F icon
41
Ford
F
$49.1B
$1.1M 0.79%
65,000
+1,700
+3% +$28.7K
2013 Q2
1 quarter
SRPT icon
42
Sarepta Therapeutics
SRPT
$1.88B
$1.02M 0.73%
21,650
-400
-2% -$15.4K
2013 Q2
1 quarter
MRK icon
43
Merck
MRK
$358B
$981K 0.7%
21,589
-1,257
-6% -$57.4K
2013 Q2
1 quarter
DRCO
44
DELISTED
DYNAMICS RESEARCH CORP
DRCO
$972K 0.7%
127,882
+18,412
+17% +$118K
2013 Q2
1 quarter
OVV icon
45
Ovintiv
OVV
$18.3B
$964K 0.69%
11,160
-20
-0.2% -$1.74K
2013 Q2
1 quarter
RLH
46
DELISTED
Red Lions Hotel Corporation
RLH
$944K 0.68%
179,137
– –
2013 Q2
1 quarter
MNR icon
47
DELISTED
Monmouth Real Estate Investment Corp
MNR
$936K 0.67%
103,200
+1,000
+1% +$9.48K
2013 Q2
1 quarter
O icon
48
Realty Income
O
$52.6B
$894K 0.64%
+23,220
New +$941K
2013 Q3
0 quarters
NSC icon
49
Norfolk Southern
NSC
$73B
$862K 0.62%
11,150
-500
-4% -$37.5K
2013 Q2
1 quarter
KYN icon
50
Kayne Anderson Energy Infrastructure Fund
KYN
$2.36B
$845K 0.61%
23,580
+300
+1% +$10.8K
2013 Q2
1 quarter

Similar funds

Benchmark Capital Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Benchmark Capital Advisors held 157 positions worth $139M, up 7.4% from $130M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Benchmark Capital Advisors's Q3 2013 filing shows 14 new, 39 increased, 52 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 53,400 shares worth $2.47M. The largest sale was Ligand Pharmaceuticals, an estimated $1.98M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 24% a quarter earlier, followed by Energy and Technology.

  • Benchmark Capital Advisors's largest Q3 2013 buy was Bristol-Myers Squibb: 53,400 shares worth $2.47M.
  • Benchmark Capital Advisors added most to Vodafone in Q3 2013, an estimated $2.49M increase.
  • Benchmark Capital Advisors's biggest Q3 2013 reduction was Howard Hughes, cutting an estimated $1.7M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $1.98M.
  • Benchmark Capital Advisors's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
  • Benchmark Capital Advisors opened 14 new positions and closed 19 in Q3 2013.
  • Benchmark Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $139M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.